Novo Nordisk Insulin Revenue Drives 1Q Profits

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

May 1 (Bloomberg) -- Bloomberg Europe business correspondent Caroline Hyde reports that Novo Nordisk A/S announced a 28 percent increase in first-quarter profit as sales climbed for its insulins and the Victoza diabetes treatment. She speaks on Bloomberg Television's "The Pulse."

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change